GreenLight Biosciences Holdings, PBC Annual Operating Income (Loss) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GreenLight Biosciences Holdings, PBC quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2022.
  • GreenLight Biosciences Holdings, PBC Operating Income (Loss) for the quarter ending March 31, 2023 was -$28.3M, a 23.1% increase year-over-year.
  • GreenLight Biosciences Holdings, PBC Operating Income (Loss) for the twelve months ending March 31, 2023 was -$155M, a 25% decline year-over-year.
  • GreenLight Biosciences Holdings, PBC annual Operating Income (Loss) for 2022 was -$164M, a 51% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$164M -$55.4M -51% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$109M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.